Fidelity Investments’s Climb Bio, Inc. Common Stock CLYM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.46K | Buy |
7,627
+4,977
| +188% | +$6.17K | ﹤0.01% | 4543 |
|
|
2025
Q1 | $3.23K | Sell |
2,650
-10,913
| -80% | -$13.3K | ﹤0.01% | 4804 |
|
|
2024
Q4 | $24.4K | Buy |
13,563
+13,547
| +84,669% | +$24.4K | ﹤0.01% | 4132 |
|
|
2024
Q3 | $81 | Buy |
+16
| New | +$81 | ﹤0.01% | 5115 |
|
|
2022
Q3 | – | Sell |
-9
| Closed | – | – | 5496 |
|
|
2022
Q2 | $0 | Sell |
9
-85
| -90% | – | ﹤0.01% | 5584 |
|
|
2022
Q1 | $1K | Buy |
+94
| New | +$1K | ﹤0.01% | 4864 |
|